http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36815908

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 68
issn 2095-1779
issueIdentifier 1
pageRange 52-68
publicationName Journal of pharmaceutical analysis
startingPage 52
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_483a7c5d5110e1522b3dfb6c540c833d
bibliographicCitation Yang T, Yuan J, Peng Y, Pang J, Qiu Z, Chen S, Huang Y, Jiang Z, Fan Y, Liu J, Wang T, Zhou X, Qian S, Song J, Xu Y, Lu Q, Yin X. Metformin: A promising clinical therapeutical approach for BPH treatment via inhibiting dysregulated steroid hormones-induced prostatic epithelial cells proliferation. Journal of Pharmaceutical Analysis. 2024 Jan;14(1):52–68. doi: 10.1016/j.jpha.2023.08.012.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f25361cc1c21c35fe3f10a63c13e874
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcba2b90a1b534afb38635295ddb2c42
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c63fdc1a91ed0e883ce45094b550d6ab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0914fa7048a95c49bc4b1838d0c4648
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce157678e2e61afe791082602b972fbc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a618c250be173740572de6bbd6e672f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8fe69a1009543d787daf8b45b47dca3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_312822dbe6171077191cbec7c68cf4b6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83e47b32a5a21e1ffba5135d712557ec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f31188235f48756200236cb91dffa58
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57b6176ac5348be1a564be13a848dd92
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f9aa58d22d7be38b06b1a9871a49a5b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0846d29a747f2ff2494eed9331a5e03d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc6059b3fd0badbc7cc82a071d4f2260
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad225c65c34958f3c3e6d1061ece471e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a69842bb27df021370e9d2d34b2ebe78
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7509b27a26b30df7f705ffaf3099635
date 202401
identifier https://pubmed.ncbi.nlm.nih.gov/PMC10859540
https://doi.org/10.1016/j.jpha.2023.08.012
https://pubmed.ncbi.nlm.nih.gov/38352949
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42873
https://portal.issn.org/resource/ISSN/2095-1779
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Metformin: A promising clinical therapeutical approach for BPH treatment via inhibiting dysregulated steroid hormones-induced prostatic epithelial cells proliferation

Total number of triples: 37.